ALA · Arovella Therapeutics Limited
0.065
AUDUnlock stock Insights
Create a free account to unlock price targets, recommendations, and commentary.
Overview
Market Cap
AU$78.58M
PE
0.00
EV/EBITDA
N/A
DIV Yield
0%
Franking
0%
MQV Rating
5Very Weak
As at 20/07/2026 12:00:00 AM
Price Chart
Description
- All-Companies
- GROWTH AUS
- HALO Ords
- Hammer Bullish
Key Fundamentals
EPS 3 yr Growth
-56.70%
EBITDA Margin
NaN%
Operating Cashflow
-$7m
Free Cash Flow Return
-44.30%
ROIC
-48.00%
Interest Coverage
N/A
Quick Ratio
14.20
Performance
52 weeks range
Low 0.06 - 0.12
Trade Value (12mth)
AU$23,224.00
1 week
1.56%
1 month
-7.14%
YTD
-30.11%
1 year
-38.1%
All time high
14.78
Additional Data
Shares Outstanding (Fully Diluted)
1,196m
HALO Sector
Healthcare
Next Company Report Date
02-Sep-26
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Health Scores
Short Term
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Halo Model
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Momentum
Price
Weak
Earnings
Very Weak
Growth
Earnings
Very Weak
Dividends
Very Weak
Quality
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Valuation
Value
Consensus
Yield
News & Announcements
| Date | Event |
30 June 26ASXD | |
30 June 26ASXD | |
30 June 26ASXD | |
25 June 26ASXD | |
10 June 26ASXD |
